Vadim Alexandre talks about Novacyt's contractual dispute with the DHSC

11:29, 15th April 2021

Disclaimer
The content of this podcast / blog (or content associated with it) is not intended as investment advice and people featured may hold positions in the companies they talk about. Please do your own research.

If you find this podcast useful please give it a rating and review on iTunes by clicking here


On today's Vox Markets Podcast: Vadim Alexandre talks about Novacyt's contractual dispute with the DHSC

Vadim Alexandre, Head of Healthcare at SP Angel discusses Novacyt's #NCYT  contractual dispute with DHSC, which they say will have a material impact on Q4 2020 revenues.


TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

    Watchlist